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What can companies do to support HIV-positive workers? 
Recommendations for medium and large sized African workplaces 
 
Introduction and overview 
Over 22 million people in sub-Saharan Africa are HIV-positive (UNAIDS/WHO, 2009). More than 
90% of HIV-positive people are adults in the prime of their lives (ILO, 2008). In 2008 the adult 
(15 – 49 years) prevalence rate across sub-Saharan Africa was 5.2% (UNAIDS/WHO, 2009) 
with markedly higher rates in certain countries and sub-populations. The nine southern-most 
countries in Africa all have an adult HIV prevalence rate above 10%, with Swaziland (26%), 
Botswana (24%) and Lesotho (23%) suffering the greatest adult prevalence (UNAIDS/WHO, 
2009). In Zimbabwe, the country in which our interviews with workers were conducted, the adult 
HIV rate was 14% in 2009 (ZMoH 2009). Labourers in mining and transportation have higher 
HIV risk due to factors such as long periods of time spent living away from spouses 
(International Finance Corporation, 2002). For instance, miners are frequently housed in all-
male barracks at the mining site, returning home to their spouses only during holidays. 
Workplaces in sub-Saharan Africa have an important role to play in addressing HIV among their 
employees, the families of their employees, and the communities in which they operate. The 
imperative is an issue of social responsibility, with global media, shareholders and consumers 
increasingly placing the onus on companies to provide basic wellbeing support to workers, 
especially surrounding HIV in poor countries. It is also an issue of economic benefit to 
companies, since the cost of AIDS in the workforce is frequently higher than providing 
workplace HIV management, discussed further below. 
 
This paper provides recommendations on how medium and large sized workplaces can best 
support HIV-positive workers to improve productivity and fulfil their social responsibility to 
support employee health. These recommendations have been developed through (i) a review of 
the academic and grey literature on workplace HIV interventions and (ii) our own qualitative 
study of workers on antiretroviral therapy (ART).   
 
This article focuses on medium and large sized workplaces (i.e. with more than 50 staff, based 
on the European Commission definition, 2005) where workers generally remain onsite, or work 
from the same site for long periods of time (such as medium or large offices, mines, forestry 
estates and commercial farms).  Those who work from small offices or home offices, or those 
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who travel frequently and work from many different customer sites and satellite locations may 
require different supports and are beyond the scope of this paper.   
 
Social responsibility 
Companies are increasingly encountering greater expectations from consumers, shareholders 
and society more generally, of their responsibility to their workers and the communities in which 
they function (George, 2006).  Broader understandings of company accountability, the rise of 
the concept of corporate social responsibility and underlying issues of moral obligation have all 
been cited as reasons why employers ought to support HIV positive workers in sub-Saharan 
countries (George, 2006; see, for example, Anglo American, 2008 and BMW Group Member 
Profiles, 2008). Contemporary corporate social responsibility (CSR) is the integration of social, 
environmental and economic concerns into business operations. It focuses on business 
sustainability and accountability. i.e., one understanding of the CSR approach is that it requires 
support of HIV-positive workers in order to ensure a healthy workforce and long-term production 
sustainability. This approach also creates a norm and expectation of accountability. It draws 
international media, consumer and stakeholder attention to the extent to which businesses are 
accountable to the health needs of workers. 
 
Cost of untreated HIV/AIDS to African workplaces 
Untreated HIV and AIDS can significantly increase the cost of production both directly and 
indirectly. While HIV interventions demand significant economic inputs, limiting the impact of 
disease can be less costly than doing nothing to address health issues in workers (George, 
2006). The direct costs of untreated HIV/AIDS to businesses are manifold: paying for sick leave, 
medical care, death benefits and funeral costs (Elias and Taylor, 2001).  Indirect costs of illness 
and death due to untreated HIV include recruiting and retraining new employees, staff 
demoralization and strain, and the loss of experienced staff and institutional memory (Elias and 
Taylor, 2001, Matangi, 2006).  
 
The most in-depth analysis of the cost of HIV/AIDS to businesses is presented by Rosen, et al. 
(2007) and based on human resource data, financial survey data and medical data from 14 
companies in southern Africa. They found workplace HIV rates ranging from 5 to 37% and 
determined that the average cost per employee who leaves work because of untreated AIDS 
varied from 0.5-5.6 times the annual compensation of the employee affected. For example, in a 
Zambian tourism company, losing a worker to AIDS cost about US$1430, equal to just over a 
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year’s salary for a worker at that level. The largest components of the cost of losing an 
employee to AIDS were: training a replacement worker (28% of total), funeral and death 
benefits (23%) and paid sick leave (17%).  In 12 of the 14 companies examined, overall labour 
cost increases were between 0.6 and 3%. In the remaining two companies, the overall labour 
cost increases were higher, at 8.4% and 10.8%.  In this study, specific data on tea pluckers 
offered great insight into the productivity of manual workers with HIV. Tea pluckers with 
untreated HIV/AIDS were found to be 25-30% less productive over their last two years of work 
and were absent 18-50 days more than they otherwise would have been. It was possible to 
determine this difference because the weight of the tea plucked each day by each employee 
was recorded. 
 
Workers who lack health insurance will likely push themselves to continue working even when 
not physically fit to do so (Elias and Taylor, 2001).  Not only is production reduced, but safety is 
affected. Accordingly, sick workers can be a hazard to themselves and others, particularly those 
on physically demanding job sites such as mines and factories (Elias and Taylor, 2001). 
 
HIV treatment and good business 
Properly administered ART can extend the healthy life span of workers by 10 years or more 
(Walensky, et al., 2009). Research from South Africa has shown that workplace ART provision 
can achieve HIV viral suppression comparable to levels reported in developed countries 
(Charalambous, et al., 2007). Rosen, et al. (2008) found that pre-ART workers were almost 
twice as likely to report being unable to work in the previous 5-day work week than those who 
had recently begun ART. In addition, those on ART for 3-6 months were  absent on average 3 
fewer days per month than those on ART for less than 3 months. Another recent review of the 
economic outcomes of AIDS treatment reinforces these findings: work absenteeism decreased 
significantly over a worker’s first year on treatment and that ART use improved productivity 
(Beard and Feeley, 2009).  
 
Eholie, et al.’s study (2003) of an electric company in Côte d’Ivoire compared the year before 
ART provision to the two year period following ART provision. The company employed 3,500 
workers, most of whom were professionals who had trained for one to five years. Its annual 
profits were around US$5.6 million.  They found a 94% decrease in HIV-related absenteeism, 
an 81% decrease in HIV-related hospitalisations, an  8% decrease in new clinical cases of AIDS 
and a 58% decrease in HIV-related mortality. These changes brought about by ART resulted in 
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savings of over half a million dollars (USD) in the two years, including US$287 000 saved due to 
reduced absenteeism.  
 
 
Methodology 
Review of the literature 
Literature on workplace HIV interventions published between 2000 and 2010 was reviewed, 
focusing on HIV-positive worker support. For academic papers, the key search terms were: 
([HIV OR AIDS] AND [intervention OR program*]) AND (antiretroviral OR ART OR ARV) AND 
(work* OR employ* OR company OR companies OR business*) as well as ([organizational 
support OR human resource management] AND [HIV OR AIDS]) in Scopus, CINAHL and Web 
of Knowledge. Reference lists from key articles were scanned to identify further studies for 
possible inclusion. Internet searches of the grey literature were then performed using the same 
key terms listed above, followed by a focussed examination of publications from the 
International Labour Organization (ILO), World Economic Forum (WEF), South African Business 
Coalition on HIV & AIDS (SABCOHA), Joint United Nations Programme on HIV and AIDS 
(UNAIDS), International Finance Corporation (IFC), Global Business Coalition on HIV/AIDS, TB 
and Malaria (GBC) and International AIDS Economics Network (IAEN). Finally, three 
established international experts on workplace HIV support were asked to identify any material 
that may have been missed.  
 
In-depth interviews with workers on ART 
To supplement findings from the literature review and provide first hand input from workers on 
ART, nine in-depth interviews with HIV-positive workers on ART were conducted in the eastern 
Zimbabwean province of Manicaland.  Ethical approval was granted by the Medical Research 
Council of Zimbabwe (Ref: A/681) and the Imperial College Research Ethics Committee (Ref: 
ICREC_9_3_13).  
 
Manicaland is a rural province which had an adult HIV prevalence rate of about 20% (Gregson, 
et al., 2010). The interviews sought to elicit descriptions of how employment helps or hinders 
adherence, and how workplaces provide support or present challenges. The respondents came 
from three workplaces:  a forestry estate with approximately 800 employees, the local 
department of a national tea estate with 85 employees in Manicaland and a gold mine with a 
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total of 500 employees. The interviews were conducted in Shona, the local language, by a 
trained researcher and later translated and transcribed into English.   
 
Chart 1: Basic information on the Zimbabwean interviewees 
Code 
name 
Age Company and position Years 
known HIV+ 
Years on 
ART 
PE 38 Forestry estate, gardener 3.0 2.0 
ML 50 Forestry estate, sawmill machine maintenance  3.5  1.0 
CO 38 Forestry estate, sawmill forklift operator 0.75 0.8 
CL 58 Mine, above ground maintenance department 
supervisor 
1.0 1.0 
JA 35 Mine, underground scraper machine operator 0.5 0.25 
NH 42 Mine, underground assistant mine overseer  0.6 1.0 
MO 35 Tea factory, foreman of tea packing and dispatching 3.0 3.0 
TE 52 Tea factory, drying department 1.5 1.0 
MA 39 Tea factory, cleaner 3.0 3.0 
Total interviews: 9 
 
Informants were recruited using opportunistic sampling at the on-site workplace-run clinics 
where (antiretrovirals) ARVs were distributed. Initial approaches were made to management, 
who then allocated head nurses to assist our access to workers.  After receiving permission 
from the head nurse at each site, staff put the researcher in touch with workers coming to collect 
medication. All who were approached agreed to be interviewed and were given two kilograms of 
soap as a token of gratitude. All the respondents were male. 
 
Analysis 
The literature review enabled the identification of 31 relevant articles. Almost all articles found in 
the search focused on Africa, with the majority focusing specifically on South Africa.  The 
articles were examined for information on workplace HIV interventions. The interviews were 
analyzed by identifying themes related to workplace support (or lack thereof), with the help of 
the qualitative data management software NVivo. Text segments pertaining to specific themes 
were coded. Coded segments were grouped under larger thematic categories.  
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Seven themes emerged from our analysis of the literature and the interviews. These themes 
were: (1) the need for workplace HIV policy, (2) elements of effective workplace voluntary 
counselling and testing (VCT), (3) workplace HIV disease management programs (DMPs), (4) 
promoting treatment uptake and minimizing attrition through confidentiality and management 
support (5) HIV-positive peer educators, (6) day to day assistance to help HIV-positive workers 
and (7) additional concerns of nutrition support, treatment of opportunistic infections and support 
to temporary/contract workers . The headings in the ‘Findings’ section below are based on these 
seven themes.  
 
 
Findings: Hands on recommendations for supporting HIV-positive workers  
 
(1) Laying the foundation for supporting HIV-positive workers: Develop and publicise a 
workplace HIV/AIDS policy 
Both literature and interviews highlighted the importance of developing and publicizing a clear 
policy on HIV/AIDS, guided by international norms and referencing national HIV policy, so that 
employers and employees understand their health rights and responsibilities.  
 
Our interviews with HIV positive workers in Zimbabwe illustrated that employees frequently 
lacked information on their company’s stance towards HIV. In fact, most interviewees stated that 
the primary reason they delayed being tested for HIV was because they feared that being found 
HIV-positive would lead to losing their jobs or being demoted or transferred to a different 
department.  
 
Some people are afraid of tests because they are afraid of losing their jobs. They 
feel an HIV positive status would threaten their position at work. They think they 
will be sacked or be removed from their comfortable jobs. (PE, 38, forestry estate 
gardener) 
 
The interviewees explained that these fears were based on rumours and witnessing the re-
assignment of workers who were constantly ill to physically easier tasks. However, informants 
noted that people were not re-assigned, demoted or fired because of HIV status but only 
because of illness. They clarified that in their workplaces, HIV status was not acknowledged as 
long as workers were able to handle the physical elements of their duties, something those on 
ART or with well managed pre-ART could do.  
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Interviewer: Does your employer consider your HIV status?  
CO (38, sawmill forklift operator): I don’t think they care that much. All they are 
concerned about is their production. 
 
The workers frequently referred to the need for clarity surrounding the rights of workers so that 
more people would be tested: 
 
CL (58, aboveground mine maintenance): I think the nurses here were very 
confident that I was still capable of carrying out my duties effectively and even my 
supervisors were very supportive. They felt I am still very able to do my duties. 
The senior management were also very supportive... 
Interviewer: Why do you think some of your colleagues are afraid of getting 
tested?  
CL: I think for many workers who are just as uneducated as I was, the problem is 
that of fear. They don’t have the correct information so they die with shame 
without even taking the HIV tests 
 
I think people should be told that these results will not be used in any way by 
decision makers in the company (CO, 38, sawmill forklift operator) 
 
 
Workers who know there is an official policy of non-discrimination and support are more likely to 
be willing to engage in workplace HIV programmes. For example, BMW South Africa has 
achieved workplace VCT rates of over 90%. This high uptake has been directly linked to their 
progressive HIV policy and guidelines released in 2000, and the larger ‘culture of trust’ 
developed thereafter (Mayet, 2002; BMW Group Member Profiles, 2008).  Based on the 
interviews and literature review, this paper suggests that a workplace HIV/AIDS policy should 
include the following elements: 
 
 An affirmation of the right of all employees to fair access to benefits, promotions, pay 
and continued employment regardless of HIV status as long as physically able to do 
so 
 A clear statement of zero tolerance for discrimination against HIV positive people 
 Directions for employees on how to take forward an HIV-related complaint 
 An affirmation of the employees’ rights to confidentiality and non-disclosure of their 
status 
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The policy should be written clearly, using language comprehensible to the employees, and 
carefully communicated to all members of the workforce (displayed publicly or sent out).  
 
(2) Identifying HIV-positive workers: Implement a workplace VCT programme tailored for 
high uptake 
HIV-positive employees who do not know their HIV status will not seek treatment. Brink (2005) 
points to lack of HIV status awareness as a prime challenge facing treatment programmes. The 
sooner HIV-positive individuals know their status, the faster they can access appropriate drugs 
and counselling, and take steps to avoid re-infection or infecting others. It is substantially more 
expensive to treat HIV at a late stage (George, 2006; Day, et al., 2003). The counselling 
element of VCT can be valuable to all who are tested, including those who do not have HIV.  
VCT has also been found to be one of the most economically viable strategies to address HIV 
because it offers great benefits to workers and is relatively low cost (Creese, et al., 2002).  
 
Convenient and accessible VCT will have higher uptake. Corbett, et al. (2006) found that uptake 
of VCT is higher if the services are offered on-site rather than through vouchers for off-site 
testing (51% uptake versus 19% in their study of a workplace in Zimbabwe).  However the 
literature reviewed and our interviews suggest that assessing whether a workplace will have 
better results by testing on- or off-site is a complex issue. A corporate decision about on-site 
testing will depend on the capacity to uphold confidentiality surrounding test results and ensure 
that presenting for testing will not result in stigmatization (Bhagwanjee, et al., 2008). 
Conversely, workplaces must ensure that workers are not coerced or pressured into being 
tested—an issue illuminated in Bhagwanjee et al’s (2008) study of VCT in a South African mine. 
This study found that provider-initiatiated, routine yearly testing, in which the entire staff were 
expected to participate, helped to normalize VCT. However they also expressed concern that 
some workers felt they had to get tested because of the need to conform to structurally induced 
social pressure.  If a workplace cannot create an appropriate on-site environment for HIV 
testing, it should facilitate off-site testing instead. Options include offering vouchers or providing 
detailed information about how to access local services.  Emphasizing that management cannot 
access the results instills worker trust in the programme’s confidentiality and leads to higher 
uptake;  having an independent organization conduct the testing is one way to increase worker 
trust (Stevens, et al., 2006; Bhagwanjee, et al., 2008).   
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Whether on- or off-site, giving workers time off to attend VCT will encourage participation. 
Thomas, et al. (2005) found that while 82% of tested workers at a South African workplace said 
they wanted to come back and get their results, only 57% actually did, primarily because of 
scheduling difficulties. Therefore, another way to encourage participation is to give out HIV 
results at the time of testing.  
 
VCT is best offered directly after or in conjunction with HIV education, which includes identifying 
sources of support for HIV-positive people. Workers will generally be more interested in being 
tested if they know there is support available if they are found to be HIV positive. Evidence 
suggests that VCT with no peer education averages 50% uptake and with high quality peer 
education 80% (Thomas, et al. 2005).  
 
 
Other stratgies to overcome reluctance for testing have also been used successfully.  One such 
strategy is to create incentive programmes such as a draw for a family vacation to all those who 
attend VCT (George, 2006).  Another strategy, used by Anglo American, a large mining 
company, is to publish the VCT uptake levels of different sections and send them to other mine 
sites so that teams can benchmark themselves against the best performing mines (Brink and 
Pienaar, 2007).  In this programme they were able to achieve VCT uptake around 80% in their 
mines in southern Africa.  Strong leadership support to employee uptake is also linked to 
successful testing rates (Stevens, et al., 2006; Thomas, et al., 2005). For instance, direct 
participation in testing by upper management goes a long way to overcome employee 
reluctance. Compelling evidence for the success of this strategy was found by Stevens, et al. 
(2006): the only unit in their study that achieved 100% VCT was one lead by  a particularly 
enthusiastic unit leader.  Sites with less supportive leaders generally had low uptake.  ART 
expert Sean Jolly, chief executive of Lifeworks, an HIV management firm, found that strong 
organizational support can actually override stigma around VCT uptake. Lifeworks, for instance, 
achieves VCT rates of over 80% where organizational support is good. 
 
 
(3) Supporting HIV-positive workers through disease management programmes (DMPs) 
An estimated 10% of HIV-positive people at any given time require ART (George, 2006) but all 
HIV-positive people need support and monitoring. Regular HIV staging and CD4 blood cell 
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counts ensure that workers are placed on ART when it becomes necessary. Treatment for any 
subsequent infections, especially tuberculosis (TB) and sexually transmitted infections (STIs), 
as well as nutritional and lifestyle counselling are vital components of HIV management, even in 
the pre-ART phases.  
 
According to Connelly and Rosen (2005) there are four models of employer-supported HIV 
management: 
 Model 1: Employer provider: The employer internally finances and delivers treatment 
and care.  
 Model 2: Medical aid scheme: Employers subsidise medical aid scheme premiums for 
employees who choose to make the co-payment.  
 Model 3: Independent DMP: A specialised HIV/AIDS disease management company is 
contracted by an employer to manage the costs and treatment.  
 Model 4: Clinic provider: An external treatment and care provider is contracted by the 
employer to provide HIV-related services either at the workplace or at an outside clinic.  
 
The authors of this paper add an additional approach to Connelly and Rosen’s (2005) list based 
on services reported by our interviewees in Zimbabwe: 
 
 Model 5: Employer assisted public provider: The employer assists workers in accessing 
treatment from public hospitals, generally through encouraging visits and providing 
transportation.  
 
Connelly and Rosen (2005) estimate that model 1 and model 3 facilitate the highest ART uptake 
because they are generally linked to workplace VCT and outreach.  Medical aid schemes 
(model 2) tend to exclude lower-wage workers since few enrol in these programmes because of 
the cost of the co-payment; this type of scheme has the lowest uptake. In addition, medical aid 
schemes rely primarily on worker initiative to access care. 
 
The hybrid model (model 5) is popular in Zimbabwe where many employers run on-site clinics 
and link to public hospitals for drugs and medical support. This model is particularly suitable for 
medium sized enterprises because it can provide the best elements of model 1 (i.e. workplace 
outreach, links to workplace VCT and convenient access to drugs) without needing a complex 
onsite medical facility (i.e. CD4 cell count machine, laboratory, doctor).  
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(4) Promoting HIV-treatment uptake and minimizing attrition 
Low uptake of workplace DMPs and high attrition have been problems across many sectors 
(George, 2006; Connelly and Rosen, 2006; ILO, 2003; Bhagwanjee, et al, 2008). Anglo 
American in South Africa, widely considered to exhibit one of the strongest employer responses 
to HIV, has found that over 30% of those who started on ART were no longer being treated 
(Connelly and Rosen, 2006). Operational costs of DMPs increase when workers do not access 
services or default (George and Quinlan, 2008). It is vital to focus on timely worker enrollment in 
DMPs and to sustain adherance. The literature and interviews suggest that there are two key 
ways for companies to do this: once again, ensure confidentiality and provide strong support.  
 
Maintaining confidentiality 
The practical challenges of maintaining confidentiality are thought to be a central reason for high 
ART attrition (ILO, 2003). Workers have expressed concern that the rigours of disease 
management, which includes frequent visits to the clinic and, when on ART, taking a pill with 
food twice daily, will lead their colleagues to suspect that they are HIV-positive (Setwe, 2009).  
Interviewees referred to these practical issues as well:  
 
I know some senior people would go to hospital secretly to collect their 
medication and they don’t want anyone to know that they are on ART, for us, the 
lower rank workers, it would be easy to be known because we visit the [worksite] 
clinic and we gather as a group for transport to the hospital (PE, 38, forestry 
estate gardener) 
 
There are also issues around other workers seeing you taking the drugs; they will 
talk about it in a bad way and begin to label you as a patient, so it’s always good 
to take the tablets away from the crowd (CO, 38, sawmill forklift operator) 
 
...I have not told them that I am HIV positive, but I am sure they are aware 
because we just come to the clinic on a regular basis in a very open fashion (JA, 
35, mine underground machine operator). 
 
Considering these practical barriers maintaining confidentiality requires creative solutions. BMW 
successfully adapted facilities within the company to allow for better privacy during discussions 
with healthcarers (ILO, 2003). Another option is to provide workplace support that allow workers 
to access outside care if they desire, for example through a reimbursement system. Being seen 
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at the clinic on ‘ART days’ was an issue that came up in our interviews. It highlighted the fact 
that workplace clinics can consider switching from having one day per week for ART patients to 
allowing patients to come at different times throughout the week. This would enable ART 
patients to better blend in with other service users.  
 
Reducing stigma to such a degree that hiding one’s HIV status becomes less important would 
be ideal. However this is not yet a reality. Regardless of the degree of stigma associated with 
being HIV-positive, it is still the employee’s right to keep his or her HIV status private.  
 
Support from management  
Support from management is important not only in influencing VCT uptake but also in terms of 
supporting HIV-positive workers on DMPs. As a Zimbabwean worker explains, supervisors can 
make life on ART more difficult: 
 
Some departments are so busy and production oriented that one cannot take a 
minute. If a supervisor does not understand they say: “you AIDS patients are 
difficult to work with” because the worker would have asked to be excused for a 
few moments to take the drugs (TE, 52, tea factory drying department).  
 
Our interview findings suggest that supervisors must be informed that the company has a policy 
of accommodating clinic visits or time to take pills. Moreover, supervisors must be given the 
space by their managers to relax production briefly to support workers on ART. If lower-level 
managers are under intense pressure from above and do not understand the larger productivity 
benefit of supporting workers on ART, they may be frustrated by the special needs of these 
workers.  
 
(5) Day-to-day assistance to help HIV-positive workers remain healthy and productive 
 
The interviewees spoke of the importance of workplace support in the form of being given time 
off to go to the clinic and providing transportation if they had to travel off-site. Providing 
transportation to clinics or onsite care can increase efficiency by reducing the time, money and 
energy workers must expend on HIV-management as the following quotation illustrates: 
 
The company has been very supportive, I am sure now the nurses are given free 
transport to go and collect our ARVs every month so that we just conveniently 
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collect our drugs from this company clinic. We don’t need to go to [name deleted] 
hospital because the company provides transport for the drugs to be brought here 
(CO, 38). 
 
In addition, several interviewees noted that disruptions in routine can lead to taking pills late; 
workplaces should seek to maintain predictable hours for HIV-positive workers.  
 
Most workers on ART also want to continue in their original positions for as long as possible but 
may need some accommodation, such as longer breaks or modified duties. Continuing to work 
in approximately the same capacity is economically important and also affirms their personal 
and social identity as ‘normal’ and productive people. The following quotations explain:  
 
I feel I am the same as workers who are not infected with HIV/AIDS ... The only 
problem comes with people who begin to perceive a person as an HIV sufferer 
and hence put boundaries on what one can and cannot do. Otherwise I feel I am 
just as good as anyone who is HIV negative, except the fact that I take my pills 
every day. There is nothing that can stop me from achieving the best at work. (JA, 
35, underground mine scraper machine operator) 
 
Being HIV positive makes me work even harder so that I prove my HIV status 
does not make me a less desirable employee. (MO, 35, tea factory foreman) 
 
I have regained enough strength to do all my chores, therefore I no longer feel 
like a patient when I am at work. (CL, 58, above-ground mine maintenance)  
 
However, even well managed HIV has some adverse effects on the physical capacities of 
workers, particularly as treatment time advances.  As discussed in the ILO’s (2003) Workplace 
action on HIV/AIDS: identifying and sharing best practice employers should—and are often 
obligated, according to national disability legislation—make reasonable accommodations for 
HIV-positive workers for as long as possible within the same job. 
 
(6) Provide a platform for HIV-positive peer educators 
Businesses can provide a platform for peer education involving willing HIV-positive workers. 
Peer education is a practical and inexpensive initiative that can simultaneously meet important 
social and psychological needs of HIV-positive workers. This helps develop an open and 
supportive workplace environment that encourages other employees to be tested and take up 
treatment if needed. De Coito (2005) examined factors affecting enrolment onto workplace ART. 
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He recommended involving people living with HIV to reduce the stigma surrounding testing and 
treatment. Although peer education programmes surrounding HIV have been extensively 
discussed and endorsed, the specific desire and capacity of HIV-positive workers to act as 
educators is under-explored and came out a central theme in our qualitative research. Peer 
education performed by HIV-positive people can make a strong contribution to outreach and 
stigma reduction. 
 
Every HIV-positive worker interviewed engaged in some form of peer education. The following is 
an example: 
 
I have disclosed even to my workmates [who were] complaining of same kind of 
illness that I used to have. I encourage them to consider getting tested for HIV.  
Some wouldn’t appreciate the advice but when they decided to get tested they 
would come back and express their gratitude. I’ve disclosed to many people that I 
used to have “on and off” illnesses but after taking HIV tests and following 
through the procedure I am now happy and ok. (PE, 38, forestry estate gardener) 
 
Several interviewees explicitly discussed their desire to talk to and teach colleagues about HIV: 
 
Maybe support groups: people should unite and meet doing programmes such as 
growing herbs, teaching others and so on (MO, 35, tea factory foreman).  
  
Harnessing the interest shown by HIV-positive workers to encourage VCT uptake and facilitate 
better understanding of HIV among workers will also support HIV-positive workers themselves. 
It recognizes and affirms the knowledge and capacities of HIV-positive employees.  
 
(7) Additional elements: Nutrition, opportunistic infections and temporary/contract 
workers 
Improve nutrition 
Although issues surrounding accessing appropriate food did not come up in the interviews, 
according to several comprehensive studies (Setwe, 2009; Elias and Taylor 2001), workplace 
wellness must include not only suppressing the viral load through ART but also reconstituting 
and maintaining the immune system by ensuring proper nutrition for an employee on ART. The 
ILO (2001) Code of Good Practice on HIV/AIDS in the World of Work recommends providing 
nutritional supplements to HIV-positive workers. Skovdal, et al. (under review) found that the 
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struggle to find nutritious food and the discomfort of taking ARVs on an empty stomach led 
some patients to discontinue treatment.  
 
Address opportunistic infections (OIs) 
The ILO (2003) stresses that comprehensive workplace responses to HIV must include testing 
and treatment for OIs, such as TB and STIs. HIV-positive people are more vulnerable to TB and 
STIs since they may lack the CD4 blood cells to fight these infections. TB and STIs can radically 
weaken people living with HIV/AIDS. These infections can also spread through the workplace. 
TB is a major work-related concern since it can be contagious when left untreated. STIs are a 
major aggravator for HIV transmission; STI treatment can play a major role in HIV prevention 
(WHO, 2006).  Many of those interviewed experienced severe opportunistic infections prior to 
accessing ART and relied on support from workplace clinics in dealing with these infections.  
 
Reach temporary employees and contractors 
Temporary employees and contractors are most vulnerable to contracting HIV and not receiving 
workplace disease management. George (in press) has found that temporary employees and 
contract workers (often migrants) in South African mines are more vulnerable in terms of HIV 
risk, HIV testing behaviours and ART uptake. In their study of workforce prevalence in southern 
Africa, Evian, Fox, MacLeod, Slotow and Rosen (2004) reported that contract workers had an 
HIV prevalence rate of 23%, which was higher than the four other cadres of workers: managers 
(4.5), skilled (10.5), semi-skilled (18.7) and unskilled (18.3) workers. Reaching out to these 
particularly vulnerable populations requires providing HIV-related information that is sensitive to 
the target group’s language and culture. 
  
Conclusion 
While there was striking consistency in experience and opinion about HIV support at the 
workplace among those interviewed, it is important to note that these interviews only reflect the 
opinions of a group of workers at three medium and large-sized workplaces in rural Zimbabwe; 
they may not reflect the full range of opinions on all issues. Female workers, urban workers and 
those in office work environments, for example, may feel differently about some issues. Further 
research to explore more diverse groups of workers (and also to examine small work 
environments, home office workers and mobile work—areas not addressed by this paper) would 
be beneficial. Nonetheless, the insight into the lived experiences of workers on ART provided by 
these interviews enriched our findings and confirmed conclusions from the literature review.  
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This paper provides recommendations for businesses on how to support HIV-positive workers. It 
provides practical strategies for workplaces on how to encourage VCT and support the health of 
HIV-positive workers, including strategies to improve ART access and adherence.  Workplace 
HIV management requires meeting the physical, social and emotional needs of employees. 
Doing so involves improving HIV-related medical care through providing ART, assisting with 
nutrition, and providing care for OIs.  It also requires reducing fear of disclosure and stigma by 
developing and supporting an HIV policy, emphasizing confidentiality, and bringing top and 
middle management onside. Additionally, it involves respecting the capacities and attributes of 
HIV-positive workers by accommodating their workplace-related needs (such as lighter tasks) 
and encouraging peer-education.  
 
Business responses to HIV have been improving steadily, particularly as ART becomes more 
widely affordable and available across sub-Saharan Africa. In addition to social responsibility, 
there are many practical reasons for companies to support HIV-positive workers: financial gains 
of maintaining worker productivity, increased employee satisfaction and improved public image.   
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